Adamed Technology

Adamed Technology Sp. z o.

Corporate Fund  |
Poland, Warszawa

Primary tabs

About your organization / profile

Adamed Technology Sp. z o.o. is the investment arm of the Adamed group. Adamed is the second-largest pharmaceutical company in Poland. The company was founded nearly 40 years ago and has been growing dynamically since then. The core business of Adamed consists of generic drugs. However, over 20 years ago, the company began research into innovative drugs, becoming a pioneer in drug discovery among private Polish pharmaceutical companies.

 

Today, Adamed's product portfolio covers 19 therapeutic areas, and the company's products reach markets in over 70 countries, in 9 of which through entities belonging to the Adamed group. Adamed's global revenues amount to approximately 0.5 billion USD.

 

One of the areas of interest for Adamed Technology is investments in startup projects. In this regard, we operate organizationally and decision-wise independently from the group's pharmaceutical business. However, we utilize its expertise or specialized resources when appropriate. We have a financial investor mindset. Our goal is to achieve a return on investment, not to take majority shares, take over companies, or exclusively incorporate startups' products and technologies into our pipeline or portfolio.

 

We invest exclusively in projects that we understand. This means we are interested in projects that directly pertain to the sphere of health and its protection. Although we are affiliated with a pharmaceutical company, our investment interests extend beyond those typical for the industry.

 

We are an evergreen fund, which allows us greater patience regarding the expected return period. We understand how much time is needed to develop truly innovative medical technology. On the other hand, we expect a clear and realistic exit strategy from the very beginning. We prefer trade sales over IPOs as an exit form, though we do not exclude projects that consider IPOs.

 

We do not use public funds for investments, so our investments are not associated with the requirements that may accompany such instruments. In our case, classic equity investments are possible, as well as convertible debt or SAFE or similar instruments (e.g., BSA AIR). We are open to co-investments. We do not take on the role of lead investor in markets where we lack prior transactional experience.

Network (0)

There are no organizations in the network.

Recent activities

Avatar

Adamed Technology Sp. z o. has been awarded the InvestEU Portal  label.

Avatar